TITLE

Increased gut permeability in Crohn's disease: is TNF the link?

PUB. DATE
December 2004
SOURCE
Gut;Dec2004, Vol. 53 Issue 12, p1724
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
18384797

 

Related Articles

  • Anti-tumor necrosis factor treatment restores the gut barrier in Crohn’s disease Suenaert, Peter; Bulteel, Veerle; Lemmens, Liesbeth; Noman, Maja; Geypens, Benny; Assche, Gert Van; Geboes, Karel; Ceuppens, Jan L.; Rutgeerts, Paul // American Journal of Gastroenterology;Aug2002, Vol. 97 Issue 8, p2000 

    OBJECTIVES:A primary defect of the tight junctions and, hence, increased intestinal epithelial permeability has been proposed as a basic pathogenic event in Crohn’s disease. Challenge of the mucosal immune system by the commensal gut flora would then result in chronic inflammation....

  • Increased Intestinal Permeability in Patients with Crohn's Disease and Their Relatives. Hollander, Daniel; Vadheim, Constance M.; Brettholz, Edward; Pettersen, Gloria M.; Delahunty, Thomas; Rotter, Jerome I. // Annals of Internal Medicine;Dec86, Vol. 105 Issue 6, p883 

    Presents a study that examined the role of increase intestinal permeability in patients with Crohn's disease. Causes of Crohn's disease; Methodology of the study; Discussion on the result of the study.

  • Slipping the barrier: how variants in CARD 15 could alter permeability of the intestinal wall and population health. Schreiber, S. // Gut;Mar2006, Vol. 55 Issue 3, p308 

    The increased intestinal permeability in Crohn's disease is associated with the presence of variants in the CARD15 gene that are regarded as causative for Crohn's disease, suggesting a genetic rather than an environmental background for intestinal Barrier dysfunction in Crohn's disease.

  • Intestinal permeability in children with Crohn's disease. Pearson, A.D.J.; Eastham, E.J.; Laker, M.F.; Craft, A.W.; Nelson, R. // British Medical Journal (Clinical Research Edition);7/3/1982, Vol. 285 Issue 6334, p20 

    Investigates the intestinal permeability in children with Crohn's disease and celiac disease in Great Britain. Administration of mannitol and lactulose to measure the intestinal permeability; Increase in permeability in patients with Crohn's disease due to lactulose; Differences between...

  • The Effect of Cigarette Smoke Exposure on the Development of Inflammation in Lungs, Gut and Joints of TNFΔARE Mice. Allais, Liesbeth; Kumar, Smitha; Debusschere, Karlijn; Verschuere, Stephanie; Maes, Tania; De Smet, Rebecca; Conickx, Griet; De Vos, Martine; Laukens, Debby; Joos, Guy F.; Brusselle, Guy G.; Elewaut, Dirk; Cuvelier, Claude A.; Bracke, Ken R. // PLoS ONE;11/2/2015, Vol. 10 Issue 10, p1 

    The inflammatory cytokine TNF-α is a central mediator in many immune-mediated diseases, such as Crohn’s disease (CD), spondyloarthritis (SpA) and chronic obstructive pulmonary disease (COPD). Epidemiologic studies have shown that cigarette smoking (CS) is a prominent common risk factor...

  • Too soon to blame measles for gut disease. Bell, Ruth // New Scientist;12/4/93, Vol. 140 Issue 1902, p18 

    Reports on Royal Free Hospital's Andrew Wakefield's suggestion that the measles virus is causing Crohn's disease. Link between Crohn's and measles vaccine; Finding evidence of measle virus in blood vessels supplying the gut of people with Crohn's; Lack of a consistent evidence; Criticisms.

  • CORRECTION.  // Gut;May2005, Vol. 54 Issue 5, p734 

    Presents a correction for the article "Impact of the Increasing Use of Immunosuppressants in Crohn's Disease on the Need for Intestinal Surgery" that was published in a 2005 issue of the periodical "Gut."

  • Crohn's Disease and Intestinal Bacteria. Klotter, Jule // Townsend Letter;Jun2013, Issue 359, p20 

    The article reports on the connection between potentially disease-causing bacteria called pathobionts and Crohn's disease (CD). According to Dutch researcher Hermie J. M. Harmsen and colleagues, people with CD experience chronic gut inflammation because of a heightened immune response to...

  • Vedolizumab as a Treatment for Crohn's Disease and Ulcerative Colitis. Ha, Christina; Kornbluth, Asher // Gastroenterology & Hepatology;Dec2014, Vol. 10 Issue 12, p793 

    The management of Crohn's disease and ulcerative colitis has become increasingly complex. With the current utilization of immunosuppressive therapies earlier in the disease course for patients presenting with moderate to severe disease, there is a great need for additional biologic agents...

  • Intestinal-Specific TNFα Overexpression Induces Crohn’s-Like Ileitis in Mice. Bamias, Giorgos; Dahman, Mohamed I.; Arseneau, Kristen O.; Guanzon, Mitchell; Gruska, Dennis; Pizarro, Theresa T.; Cominelli, Fabio // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    Background and Aim:Human and animal studies have clearly established tumor necrosis factor (TNF)α as an important mediator of Crohn’s disease pathogenesis. However, whether systemic or only local TNFα overproduction is required for the development of chronic intestinal inflammation...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics